Common (>10%): Almost nothing reported. Most users report no acute effect.

Less common (1-10%): Mild GI changes in first week (constipation, bloating, or transient diarrhea — usually resolves). Mild taste / aftertaste with powder forms.

Rare-serious (<1% reported): Allergic reaction in milk-protein-allergic individuals (rash, swelling, anaphylaxis in severe milk allergy). No hepatotoxicity, no nephrotoxicity, no cardiotoxicity in clinical trials or post-marketing surveillance.

Theoretical concerns:

• Hereditary hemochromatosis / iron overload conditions. Lactoferrin is an iron-handling protein; theoretical concern in HFE C282Y homozygotes or other iron-overload conditions. Not contraindicated but worth monitoring ferritin if used. For most users without iron-overload genotype, not a concern.
• Milk-protein allergy. Bovine lactoferrin is purified from cow's milk whey. Severe milk protein allergy is contraindication. Casein vs whey allergies differ; lactoferrin is whey-derived. Recombinant human lactoferrin (talactoferrin) is an alternative but not commercially available as supplement.
• Lactose intolerance. NOT a contraindication. Purified bovine lactoferrin contains negligible lactose; lactose-intolerant users tolerate it.
• Long-term safety unknown for high doses. Most clinical trial data is at 100-1000 mg/day for weeks to months; chronic high-dose data is limited. Standard supplement doses (100-300 mg/day) have decades of dietary exposure precedent (breast milk, dairy) supporting safety.
• Drug interactions with iron / mineral absorption. Lactoferrin handles iron specifically; other minerals (calcium, zinc, magnesium) may compete for absorption channels at high doses. Standard supplement timing rules apply (separate calcium 2hr, separate levothyroxine 4hr from any iron-containing protocol).

Specific watch periods: First 1-2 weeks for any GI tolerance issue. Week 4 reassessment for tolerability. For anemia / H. pylori protocols, biomarker reassessment at 8-12 weeks.

Why lactoferrin is unusually safe for an immune-modulator: It's an endogenous human glycoprotein (humans produce it continuously in milk, tears, saliva, neutrophils). The bovine form has high homology with the human form. Decades of dietary exposure (breast milk delivers grams of lactoferrin to infants) and supplement exposure (since the 1990s) without major safety signals. The mechanism (iron sequestration + TLR4 modulation) is benign at supplement doses. GRAS status (FDA GRN 464) confirms regulatory comfort.